In the quest for improved influenza vaccines and conserved immunogenic epitopes which can induce broadly reactive protection, neuraminidase has been identified as a candidate for use as a vaccine antigen that can potentially elicit broadly reactive NA-specific protective immune responses against heterologous viruses (2, 10, 11). This evidence concerns the gene XK and influenza.